Case Report: Repeated Series of Ketamine Infusions in Patients With Treatment-Resistant Depression: Presentation of Five Cases
Purpose: Approximately 30% of patients with major depressive disorder (MDD) are treatment resistant. There is an unquestionable need for new treatment strategies. Subanesthetic doses of intravenous (IV) ketamine have a rapid antidepressant effect in treatment-resistant depression (TRD). This paper d...
Enregistré dans:
Auteurs principaux: | Maria Gałuszko-Wȩgielnik, Adam Włodarczyk, Wiesław Jerzy Cubała, Alina Wilkowska, Natalia Górska, Jakub Słupski |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/32bae4a593b64cee95bf4471b5209d28 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
par: Wilkowska A, et autres
Publié: (2021) -
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression
par: Szarmach J, et autres
Publié: (2020) -
Ketamine in Bipolar Disorder: A Review
par: Wilkowska A, et autres
Publié: (2020) -
Clozapine As Transformative Treatment In Bipolar Patients
par: Wilkowska A, et autres
Publié: (2019) -
Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review
par: Michael Colla, et autres
Publié: (2021)